Early-onset Parkinson disease
STR: JPH3_HDL2_CTG
NM_001271604.2:c.431CTG[X] or NM_020655.4:c.382+760CTG[X]
In an alternatively spliced exon, the repeat can be transcribed in both directions, leading to CUG (more common) or CAG (less common) repeat-containing transcripts. While a dominant RNA toxic effect may occur, the repeat expansion also reduces levels of the Junctophilin-3 protein
Normal: ≤28 repeats
Questionable significance: 29-39 repeats, mutable normal or reduced penetrance included
Full penetrance: ≥40 repeatsCreated: 26 Apr 2025, 11:41 p.m. | Last Modified: 26 Apr 2025, 11:41 p.m.
Panel Version: 2.26
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Huntington disease-like 2 MIM#606438
Publications
Variants in this STR are reported as part of current diagnostic practice
Clinically RelevantInterruptions in the repeated sequence are reported as part of standard diagnostic practise
Str: jph3_hdl2_ctg has been classified as Green List (High Evidence).
Str: jph3_hdl2_ctg has been classified as Green List (High Evidence).
STR: JPH3_HDL2_CTG was added STR: JPH3_HDL2_CTG was added to Early-onset Parkinson disease. Sources: Literature Mode of inheritance for STR: JPH3_HDL2_CTG was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for STR: JPH3_HDL2_CTG were set to 11558794; 20301701 Phenotypes for STR: JPH3_HDL2_CTG were set to Huntington disease-like 2 MIM#606438 Review for STR: JPH3_HDL2_CTG was set to GREEN STR: JPH3_HDL2_CTG was marked as clinically relevant STR: JPH3_HDL2_CTG was marked as current diagnostic